Insight Molecular Diagnostics

IMDX

Börsenwert 75,6 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	1 Broadwood Capital New York	15,9 Mio. $	+13,1 Mio. $	+198.413	+110 %
2	2 Vanguard Group Malvern, Pennsylvania	747.000 $	-4.427 $	-67	-0,4 %
3	3 BlackRock New York	431.000 $	-6.608 $	-100	-1 %
4	AG 4 Artal Group Luxembourg	315.000 $	–	–	–
5	5 Bridgeway Capital Management Houston, Texas	242.000 $	-99.123 $	-1.500	-21 %
6	6 Northern Trust Chicago, Illinois	92.000 $	+66 $	+1	+0 %
7	7 Destination Wealth Management Walnut Creek, California	62.000 $	–	–	–
8	8 Goldman Sachs New York	61.000 $	+96.546 $	+1.461	Neu
9	9 Geode Capital Management Boston, Massachusetts	50.000 $	+5.551 $	+84	+8 %
10	10 State Street Boston, Massachusetts	39.000 $	+7.666 $	+116	+15 %
11	11 Citadel Advisors Miami, Florida	37.000 $	+58.747 $	+889	Neu
12	12 Morgan Stanley New York	34.000 $	+132 $	+2	+0,2 %
13	13 New York State Common Retirement Fund Albany, New York	33.000 $	–	–	–
14	14 Janney Montgomery Scott Philadelphia, Pennsylvania	27.000 $	+43.085 $	+652	Neu
15	15 California State Teachers Retirement System (CalSTRS) West Sacramento, California	13.000 $	–	–	–
16	16 UBS Group Zurich, Switzerland	12.000 $	+2.247 $	+34	+13 %
17	17 Deutsche Bank Frankfurt Am Main Ge, Germany	10.000 $	-11.234 $	-170	-40 %
18	18 Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada	10.000 $	+8.723 $	+132	+136 %
19	19 STRS Ohio Columbus, Ohio	9.000 $	–	–	–
20	20 American International Group New York	5.000 $	-396 $	-6	-5 %
21	21 Tower Research Capital (TRC) New York	3.000 $	+1.850 $	+28	+82 %
22	22 Bank of Montreal Toronto, Ontario, Canada	3.000 $	+4.229 $	+64	+2.133 %
23	23 JP Morgan Chase New York	2.000 $	-991 $	-15	-28 %
24	24 Bank of America Charlotte, North Carolina	2.000 $	-529 $	-8	-23 %
25	25 Barclays London, United Kingdom	2.000 $	+595 $	+9	+29 %

Insight Molecular Diagnostics IMDX Börsenwert 75,6 Mio. $

Insight Molecular Diagnostics

IMDX

Börsenwert 75,6 Mio. $